G

Galectin Therapeutics
D

GALT

3.92000
USD
-0.13
(-3.09%)
مغلق
حجم التداول
7,228
الربح لكل سهم
-0
العائد الربحي
-
P/E
-9
حجم السوق
395,330,604
أصول ذات صلة المقالات
المزيد

العنوان: Galectin Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.